Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) StudyPlain-Language Summary

Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) StudyPlain-Language Summary

Rationale and Objective: Chronic kidney disease is a risk enhancing factor for cardiovascular disease (CVD) and mortality, and the role of aspirin use is unclear in this population. We investigated the risk and benefits of aspirin use in primary and secondary prevention of CVD in the Chronic Renal I...

Full description

Bibliographic Details
Main Authors: Jonathan J. Taliercio, Georges Nakhoul, Ali Mehdi, Wei Yang, Daohang Sha, Jesse D. Schold, Scott Kasner, Matthew Weir, Mohamed Hassanein, Sankar D. Navaneethan, Geetha Krishnan, Radhika Kanthety, Alan S. Go, Rajat Deo, Claudia M. Lora, Bernard G. Jaar, Teresa K. Chen, Jing Chen, Jiang He, Mahboob Rahman, Lawrence J. Appel, MD, MPH, Debbie L. Cohen, MD, Harold I. Feldman, MD, MSCE, James P. Lash, MD, Robert G. Nelson, MD, PhD, MS, Panduranga S. Rao, MD, Vallabh O. Shah, PhD, MS, Mark L. Unruh, MD, MS
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:Kidney Medicine
Subjects:
Aspirin
bleeding
cardiovascular disease
chronic kidney disease
CKD
CRIC Study
Online Access:http://www.sciencedirect.com/science/article/pii/S259005952200173X

Internet

http://www.sciencedirect.com/science/article/pii/S259005952200173X

Similar Items